HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rakesh Kumar Selected Research

Nucleosomes (Nucleosome)

1/2022Role of epigenetics in carcinogenesis: Recent advancements in anticancer therapy.
12/2014Role of MTA1 in head and neck cancers.
12/2014MTA family of proteins in DNA damage response: mechanistic insights and potential applications.
2/2012Metastasis-associated protein 1 drives tumor cell migration and invasion through transcriptional repression of RING finger protein 144A.
1/2012Metastasis-associated protein 1/nucleosome remodeling and histone deacetylase complex in cancer.
5/2011Bidirectional autoregulatory mechanism of metastasis-associated protein 1-alternative reading frame pathway in oncogenesis.
2/2011Gene profiling of MTA1 identifies novel gene targets and functions.
7/2010Regulation of NF-kappaB circuitry by a component of the nucleosome remodeling and deacetylase complex controls inflammatory response homeostasis.
3/2010Revelation of p53-independent function of MTA1 in DNA damage response via modulation of the p21 WAF1-proliferating cell nuclear antigen pathway.
10/2009E3 ubiquitin ligase COP1 regulates the stability and functions of MTA1.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Rakesh Kumar Research Topics

Disease

243Neoplasms (Cancer)
07/2022 - 02/2002
114Breast Neoplasms (Breast Cancer)
07/2022 - 01/2002
85Neoplasm Metastasis (Metastasis)
04/2021 - 03/2003
43Infections
06/2022 - 02/2004
26Carcinoma (Carcinomatosis)
07/2021 - 06/2005
20Carcinogenesis
07/2022 - 11/2002
20Angiofibroma
03/2022 - 11/2009
19Pain (Aches)
07/2021 - 07/2003
15Neuroendocrine Tumors (Neuroendocrine Tumor)
07/2021 - 11/2011
15Lymphoma (Lymphomas)
07/2019 - 11/2004
14COVID-19
10/2022 - 01/2020
14Prostatic Neoplasms (Prostate Cancer)
01/2022 - 05/2003
13Adenocarcinoma
01/2022 - 06/2005
13Inflammation (Inflammations)
01/2021 - 04/2003
12Parkinson Disease (Parkinson's Disease)
10/2020 - 05/2009
11Multiple Myeloma
07/2022 - 05/2004
11Body Weight (Weight, Body)
07/2022 - 11/2002
10Glioma (Gliomas)
07/2022 - 07/2009
10Tuberculosis (Tuberculoses)
01/2021 - 08/2004
9Type 1 Diabetes Mellitus (Autoimmune Diabetes)
11/2021 - 08/2016
8Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2022 - 07/2013
8Wounds and Injuries (Trauma)
12/2021 - 05/2009
8Lung Neoplasms (Lung Cancer)
12/2021 - 12/2004
7Alzheimer Disease (Alzheimer's Disease)
01/2022 - 01/2019
7Squamous Cell Carcinoma (Epidermoid Carcinoma)
10/2021 - 04/2003
7Carcinoid Tumor (Carcinoid)
05/2014 - 10/2009
6Acquired Immunodeficiency Syndrome (AIDS)
12/2021 - 06/2006
6Cicatrix (Scar)
07/2021 - 12/2011
6Genomic Instability
01/2021 - 07/2009
6Hypersensitivity (Allergy)
01/2020 - 01/2004
6Ovarian Neoplasms (Ovarian Cancer)
10/2019 - 07/2006
6Fibrosis (Cirrhosis)
04/2016 - 11/2004
6Necrosis
10/2015 - 04/2003
5Whooping Cough (Pertussis)
04/2019 - 01/2013
5Head and Neck Neoplasms (Head and Neck Cancer)
01/2019 - 12/2005

Drug/Important Bio-Agent (IBA)

105Proteins (Proteins, Gene)FDA Link
01/2022 - 01/2002
67Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
07/2022 - 11/2004
40Pharmaceutical PreparationsIBA
10/2022 - 09/2006
34AntigensIBA
03/2022 - 08/2002
30Phosphotransferases (Kinase)IBA
01/2021 - 02/2002
28Estrogen ReceptorsIBA
07/2020 - 02/2002
28Estrogen Receptor alphaIBA
01/2019 - 01/2002
2368Ga-DOTANOCIBA
04/2022 - 07/2012
21Hormones (Hormone)IBA
07/2022 - 02/2002
20p21-Activated KinasesIBA
01/2020 - 08/2002
19VaccinesIBA
01/2021 - 01/2008
18Biomarkers (Surrogate Marker)IBA
05/2022 - 03/2009
18Biological ProductsIBA
01/2022 - 11/2004
18Estrogens (Estrogen)FDA Link
07/2020 - 03/2002
17Pemetrexed (MTA)FDA Link
01/2021 - 04/2003
16Somatostatin Receptors (Somatostatin Receptor)IBA
01/2021 - 12/2010
15Glucose (Dextrose)FDA LinkGeneric
07/2022 - 11/2005
15LigandsIBA
01/2022 - 03/2002
15Neoplasm Antigens (Tumor Antigens)IBA
09/2015 - 05/2004
13Nucleosomes (Nucleosome)IBA
01/2022 - 05/2003
13Messenger RNA (mRNA)IBA
11/2020 - 03/2002
13DNA (Deoxyribonucleic Acid)IBA
01/2020 - 08/2003
13ErbB Receptors (EGF Receptor)IBA
01/2020 - 10/2002
12Insulin (Novolin)FDA Link
04/2022 - 10/2004
12ChromatinIBA
01/2022 - 03/2003
121,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
05/2021 - 10/2009
12Histones (Histone)IBA
08/2019 - 08/2002
12TamoxifenFDA LinkGeneric
06/2009 - 06/2004
11Peptides (Polypeptides)IBA
01/2022 - 09/2006
11Amyloid (Amyloid Fibrils)IBA
01/2022 - 02/2015
11Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2020 - 01/2002
11AcidsIBA
03/2015 - 04/2003
10Octreotide (Sandostatin)FDA LinkGeneric
05/2021 - 11/2011
10Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
09/2015 - 12/2003
10Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2015 - 05/2004
9Histone Deacetylases (Histone Deacetylase)IBA
01/2021 - 03/2003
9SynucleinsIBA
10/2020 - 12/2017
9Technetium Tc 99m MedronateIBA
06/2020 - 01/2003
9Co-Repressor ProteinsIBA
12/2014 - 08/2002
9Morphine (MS Contin)FDA LinkGeneric
04/2014 - 10/2004
8CytokinesIBA
11/2021 - 10/2004
8RNA (Ribonucleic Acid)IBA
07/2021 - 07/2007
8DiureticsIBA
05/2020 - 09/2005
8Epidermal Growth Factor (EGF)IBA
01/2020 - 03/2002
8Mi-2 Nucleosome Remodeling and Deacetylase ComplexIBA
12/2014 - 10/2009
7gallium 68 PSMA-11IBA
03/2022 - 04/2018
7Antiviral Agents (Antivirals)IBA
01/2019 - 04/2005
6MicroRNAs (MicroRNA)IBA
01/2022 - 10/2008
6EnzymesIBA
01/2021 - 06/2012
6Anti-Bacterial Agents (Antibiotics)IBA
10/2020 - 07/2003
6Neuregulin-1 (Neuregulin 1)IBA
01/2020 - 02/2002
6Fluorine-18IBA
10/2017 - 04/2006
6histidine-rich proteinsIBA
04/2005 - 02/2002
5AntioxidantsIBA
07/2022 - 04/2008
5Estradiol (Delestrogen)FDA LinkGeneric
07/2022 - 02/2002
5SteroidsIBA
01/2022 - 06/2005
5Tyrosine Kinase InhibitorsIBA
06/2019 - 04/2003
5Coloring Agents (Dyes)IBA
04/2019 - 01/2003
5AntibodiesIBA
01/2019 - 07/2007

Therapy/Procedure

114Therapeutics
06/2022 - 08/2003
36Drug Therapy (Chemotherapy)
10/2021 - 07/2003
14Radiotherapy
08/2021 - 11/2004
10Neoadjuvant Therapy
08/2021 - 02/2006
8Precision Medicine
07/2022 - 07/2011
5Length of Stay
05/2020 - 10/2005